Argan insider plans Rule 144 sale of 200 common shares

William F. Leimkuhler filed a Rule 144 notice to sell 200 shares of Argan, Inc. common stock through Fidelity Brokerage Services LLC on 12/23/2025 on the NYSE, with an aggregate market value of $67,580.00 and 13,873,410 shares outstanding.

Rhea-AI Filing Summary

William F. Leimkuhler filed a Rule 144 notice to sell 200 shares of Argan, Inc. common stock through Fidelity Brokerage Services LLC on 12/23/2025 on the NYSE, with an aggregate market value of $67,580.00 and 13,873,410 shares outstanding.

The shares to be sold were originally acquired in two open market purchases of 100 shares each on 10/07/2013 and 10/08/2013, both paid in cash. The filing also reports that during the past three months, Leimkuhler sold 11,802 securities of Argan, Inc. on 10/01/2025 for gross proceeds of $3,242,370.73.

By signing the notice, the seller represents that he is not aware of any material adverse, non-public information about Argan, Inc. and that any trading plan or instructions intended to satisfy Rule 10b5-1 were adopted without such undisclosed information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Argan (AGX) report in this Form 144?

The notice reports that William F. Leimkuhler intends to sell 200 shares of Argan, Inc. common stock on the NYSE through Fidelity Brokerage Services LLC, with an aggregate market value of $67,580.00.

When will the 200 Argan (AGX) shares covered by this Form 144 be sold?

The filing lists an approximate date of sale of 12/23/2025 for the 200 common shares of Argan, Inc. to be sold on the NYSE.

How many Argan (AGX) shares are outstanding in this Form 144 disclosure?

The securities information section states that the number of Argan, Inc. shares outstanding is 13,873,410 at the time referenced in the notice.

What were the past 3 months of Argan (AGX) insider sales reported here?

Over the past three months, William F. Leimkuhler is reported to have sold 11,802 Argan, Inc. securities on 10/01/2025 for gross proceeds of $3,242,370.73.

How and when were the Argan (AGX) shares being sold originally acquired?

The shares were acquired in two open market purchases of 100 shares each on 10/07/2013 and 10/08/2013, with cash as the nature of payment.

What representation does the seller make about non-public information on Argan (AGX)?

By signing the notice, the seller represents that he does not know any material adverse information about the current or prospective operations of Argan, Inc. that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/23/2025 - 03:21 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001361943
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARGAN INC
SEC File Number	001-31756
Address of Issuer	4075 WILSON BOULEVARD SUITE 440 ARLINGTON VIRGINIA 22203
Phone	301 315-0027
Name of Person for Whose Account the Securities are To Be Sold	Leimkuhler William F.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street boston MA 02110	200	67580.00	13873410	12/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/07/2013	Open Market Purchse	Open Market			100	10/07/2013	Cash
Common	10/08/2013	Open Market Purchase	Open Market			100	10/08/2013	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leimkuhler William F. 4075 WILSON BOULEVARD SUITE 440 ARLINGTON VA 22203	ARGAN INC	10/01/2025	11802	3242370.73

144: Remarks and Signature

Remarks	Selling 100 shares from EMILY K LEIMKUHLER TRUST U/A and 100 shares from ELIZABETH LEIMKUHLER TRUST
Date of Notice	12/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Cristina Garcia, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Leimkuhler William F.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)